To gain deeper insights into the mechanism by which 3-IAId mitigates the risk of AD formation, an investigation was conducted to assess the deposition of collagen type I (COL1a1) and fibronectin (FN) within aortic lesions using immunofluorescence (IF) staining. The gene discussed is COL1A1; the disease is Alzheimer disease.